Company intelligence / Profile preview
InnoShengKang
Changzhou, Jiangsu, Chinaqhsh.com.cn ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
InnoShengKang (Changzhou Innoshengkang Biomedical Technology Co., Ltd.) is a Chinese biotechnology company and a core subsidiary of Changzhou Qianhong Biopharma. Founded in 2011 and headquartered in Changzhou, the company specializes in the discovery and development of innovative oral small molecule therapeutics, primarily focusing on oncology and rare genetic diseases. Its research is heavily concentrated on kinase inhibitors, with specific programs targeting the PI3K (PIK3CA) pathway for indications such as Familial Adenomatous Polyposis (FAP) and various solid tumors. The company maintains a robust intellectual property portfolio in medicinal chemistry and cell cycle regulation to support its clinical development goals.
- Therapeutic areas
- OncologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on InnoShengKang.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InnoShengKang.